Krónikus obstruktív tüdőbetegség (COPD): vizsgálatok itt: Chile

6 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 2. fázisTaking people
  A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

  Where

  Chile, Concepción, Santiago, Talca, Temuco, Viña del Mar

  Életkor

  40 év and over

  People

  987 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07082738
• 3. fázisTaking people
  Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  Where

  Chillan, Recoleta, Santiago, Temuco, Viña del Mar

  Életkor

  40 év to 80 év

  People

  942 worldwide

  Run by

  Sanofi

  See details and how to joinNCT07190222 · EU 2024-518213-25-00
• 3. fázisTaking people
  Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  Where

  Santiago, Talca, Valdivia, Viña del Mar

  Életkor

  40 év to 80 év

  People

  942 worldwide

  Run by

  Sanofi

  See details and how to joinNCT07190209 · EU 2024-518016-39-00
• 3. fázisTaking people
  Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

  Where

  Curicó

  Életkor

  40 év to 80 év

  People

  981 worldwide

  Run by

  GlaxoSmithKline

  See details and how to joinNCT06959095 · EU 2024-520418-22-00
• 3. fázisTaking people
  A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

  Where

  Curicó, Quillota, Santiago, Talca, Temuco, Victoria, Viña del Mar, Vitacura

  Életkor

  40 év to 80 év

  People

  5250 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06283966 · EU 2023-507407-59-00
• 3. fázisTaking people
  A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

  Where

  Chile, Concepción, Curicó, Quillota, Santiago, Talca

  Életkor

  40 év to 80 év

  People

  990 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06883305 · EU 2024-517458-90-00